The peroxisome proliferator-activated receptor α (PPARα) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice. Effects on plasma lipoproteins and the development of atherosclerotic lesions
Tao Fu, Debnath Mukhopadhyay, Nicholas O. Davidson, Jayme Borensztajn*
Dive into the research topics of 'The peroxisome proliferator-activated receptor α (PPARα) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice. Effects on plasma lipoproteins and the development of atherosclerotic lesions'. Together they form a unique fingerprint.